Monday, 13 April 2026
Construction company GEMO is nearing completion of the National Oncology Centre at Motol University Hospital and Homolka University Hospital, with delivery scheduled for summer 2026.
The project combines a new building with the refurbishment of an existing structure to create a single complex for cancer treatment. The facility is designed to bring together inpatient and outpatient services, diagnostic units, operating theatres, laboratories and a clinical trials centre within one location.
The scheme also includes shared public areas such as a central internal corridor with amenities, along with landscaped terraces and roof spaces intended to improve the hospital environment. The layout integrates both the original and newly constructed sections around an internal atrium.
According to the contractor, construction progress has accelerated following revisions to project coordination and documentation, as well as closer cooperation with hospital representatives and medical staff. Adjustments to the design were made during the build process to better reflect operational requirements.
Hospital management indicated that oncology care will form the core function of the new centre, supported by expanded diagnostic capacity, including imaging and screening facilities. Dedicated areas for the preparation of specialised treatments, including advanced therapies, are also planned.
The centre is intended to support a more coordinated treatment process, from initial diagnosis through to therapy, while also accommodating clinical research and specialist care. Prevention and screening programmes are expected to be part of the overall concept.
In addition to patient care, the facility will include space for training and professional events, with lecture capacity and staff amenities incorporated into the design.
Once completed, the oncology centre will operate alongside existing medical services at both hospitals, forming part of a broader healthcare cluster serving patients from across the Czech Republic and beyond.
